Comparative Study Between Level I and Level II Temporomandibular Joint Arthroscopy in Wilkes Stage III Patients
Temporomandibular Joint Dysfunction (TMJD)
1 other identifier
interventional
50
1 country
1
Brief Summary
Temporomandibular joint dysfunction (TMJD) represents a common health problem. Its prevalence is nearly 31% in adults and 11% in adolescence, more common in females. Aetiologies of TMJD are multifactorial and can be attributed to both physical and psycho-social factors. Internal derangement of the temporomandibular joint (TMJ) is the most frequent disorder; with anterior disc displacement is the most common form. Wilkes has classified internal derangement into five stages; patients with stage III usually present with limited mouth opening, joint pain and deviation of jaw upon opening to the affected side. MRI is considered the gold standard for diagnosis. Treatment of TMJD include non-surgical and surgical methods. Non-surgical treatment includes instructions, pharmacotherapy, physiotherapy and occlusal splints; while surgical interventions include minimally invasive procedures (arthroscopy and arthrocentesis) and open joint surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 13, 2024
CompletedFirst Submitted
Initial submission to the registry
October 21, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedOctober 28, 2024
October 1, 2024
1 year
October 21, 2024
October 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
maximum inter-incisal opening
change of maximum inter-incisal opening, in mm.
6 months
Study Arms (1)
TMJ dysfunction
EXPERIMENTALTMJ arthroscopy
Interventions
Eligibility Criteria
You may qualify if:
- Wilkes stage III patients
You may not qualify if:
- previous TMJ surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, Asyut Governorate, 71111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Gamal Thabet, MD
MGThabet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 21, 2024
First Posted
October 28, 2024
Study Start
October 13, 2024
Primary Completion
October 13, 2025
Study Completion
October 15, 2025
Last Updated
October 28, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share